Henry Schein | HSIC - Ebitda



Henry Schein reported $256M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Agilent USD 466M 14M Jul/2025
Align Technology USD 137.61M 77.61M Mar/2025
Bruker USD 128.1M 27.1M Jun/2025
Cardinal Health USD 667M 271M Jun/2025
Charles River Laboratories USD 220.89M 2.01M Jun/2025
Cigna USD 2.86B 56M Mar/2025
Cooper Companies USD 272.7M 5.8M Jul/2025
CVS Health USD 3.58B 1.63B Jun/2025
Danaher USD 1.34B 543M Jun/2025
Dentsply International USD 197M 45M Jun/2025
Encompass Health USD 318.6M 27.8M Jun/2025
Henry Schein USD 256M 0 Jun/2025
Idexx Laboratories USD 409.44M 58.85M Jun/2025
IQVIA Holdings USD 910M 112M Jun/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
McKesson USD 1.26B 299M Jun/2025
Mettler Toledo International USD 295.89M 43.87M Jun/2025
Owens Minor USD 96.6M 12.17M Jun/2025
Quest Diagnostics USD 570M 65M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
Stryker USD 1.46B 49M Jun/2025
Tenet Healthcare USD 1.12B 14M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025
Universal Health Services USD 642.88M 40.17M Jun/2025
Waters USD 276.28M 74.81M Jun/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025
Zoetis USD 1.08B 110M Jun/2025